ArticleBMC gastroenterology2025
The neutrophil to high-density lipoprotein cholesterol ratio is associated with disease severity in hypertriglyceridemic acute pancreatitis.
Article in BMC gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe neutrophil to high-density lipoprotein cholesterol ratio (NHR) predicts disease severity in biliary pancreatitis, yet its prognostic role in hypertriglyceridemic acute pancreatitis (HTG-AP) remains unclear.
methodsThis study enrolled 421 eligible patients diagnosed with HTG-AP. Baseline comparisons were made using the Mann-Whitney U Test and Chi-Square Test. Logistic regression analysis was employed to identify risk factors for HTG-AP severity. The predictive value of NHR was assessed using the Integrated Discrimination Improvement (IDI) and the Net Reclassification Index (NRI). Restricted cubic splines (RCS) were used to evaluate nonlinear associations. Subgroup analyses further explored the correlation between NHR and HTG-AP severity.
resultsPatients with moderate/severe HTG-AP exhibited significantly higher NHR levels than those with mild disease (p < 0.001). Elevated NHR correlated with prolonged hospitalization (p = 0.016), higher rates of acute peripancreatic fluid collection (APFC) (p < 0.001) and acute necrotic collection (ANC) (p = 0.008). NHR was an independent risk factor for moderate/severe HTG-AP (p < 0.001) and improved the predictive accuracy of the risk assessment model. NHR led to only a small improvement in AUC within the model, which indicated some limitations in predicting HTG-AP severity. RCS analysis revealed a linear relationship between NHR and HTG-AP severity (p for non-linearity > 0.05).
conclusionNHR is a simple, early biomarker for predicting HTG-AP severity, offering potential utility in guiding timely clinical interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.